# PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism

> **NCT00166257** · PHASE4 · UNKNOWN · sponsor: **Foundation for Cardiovascular Research, Zurich** · enrollment: 414 (actual)

## Conditions studied

- Embolism, Paradoxical
- Heart Septal Defects, Atrial

## Interventions

- **DEVICE:** Percutaneous closure of patent foramen ovale
- **DRUG:** Medical antitrhombotic treatment

## Key facts

- **NCT ID:** NCT00166257
- **Lead sponsor:** Foundation for Cardiovascular Research, Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-02
- **Primary completion:** 2011-02
- **Final completion:** 2011-05
- **Target enrollment:** 414 (ACTUAL)
- **Last updated:** 2009-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00166257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00166257, "PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00166257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*